SCHEMBL4201166

SCHEMBL4201166

CN(C)c1ccc(-c2cncc(C#N)c2Nc2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRKCQ Q04759 13/20 0.48
EGFR P00533 2/20 0.47
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 2/20 0.41
ALOX15 P16050 2/20 0.41
MAPK1 P28482 2/20 0.41
CYP2C19 P33261 2/20 0.41
CLK4 Q9HAZ1 2/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CSNK2A1 P68400 1/20 0.41
PRKCH P24723 1/20 0.41
PRKCE Q02156 1/20 0.41
PRKCD Q05655 1/20 0.41
SLC22A12 Q96S37 1/20 0.40
USP2 O75604 1/20 0.40
HIF1A Q16665 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4186886 0.85 PRKCQ (0.52) PRKCQEGFRALDH1A1CYP1A2CYP3A4
SCHEMBL4191905 0.79 PRKCQ (0.54) PRKCQEGFRALDH1A1CYP1A2CYP3A4
SCHEMBL2971879 0.79 PRKCQ (0.51) PRKCQEGFRALDH1A1CYP1A2CYP3A4
SCHEMBL4196893 0.77 PRKCQ (0.60) PRKCQCSNK2A1PRKCHPRKCEPRKCD
SCHEMBL5469729 0.76 PRKCQ (0.68) PRKCQEGFRALDH1A1CYP1A2CYP3A4
SCHEMBL2984352 0.75 PRKCQ (0.53) PRKCQEGFRPRKCHPRKCEPRKCD
SCHEMBL2983593 0.75 PRKCQ (0.52) PRKCQEGFRPRKCHPRKCEPRKCD
SCHEMBL4186701 0.74 PRKCQ (0.57) PRKCQEGFRPRKCHPRKCEPRKCD
SCHEMBL4193621 0.74 EGFR (0.51) PRKCQEGFRALDH1A1
SCHEMBL2981627 0.73 PRKCQ (0.42) PRKCQEGFRPRKCHPRKCEPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2027093-A2 SUBSTITUTED CYANOPYRIDINES AS PROTEIN KINASE INHIBITORS Wyeth (US) 2009-02-25 EP claimed
WO-2007146323-A2 SUBSTITUTED CYANOPYRIDINES AS PROTEIN KINASE INHIBITORS WYETH (US) 2007-12-21 WO claimed
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors WYETH 2007-12-13 US claimed
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors WYETH 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors CNKSR1, MAP3K1, MAP3K6 PRKCQ 166/4885EGFR 2704/4885ALDH1A1 3084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.